AbCelex Technologies Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

AbCelex Technologies General Information

Description

Operator of a camelid antibody platform built to address food safety and livestock health issues. The company's platform offers a core proprietary technology with a demonstrated potential to establish a new paradigm in preventing and treating a number of bacterial infections at source in livestock, enabling researchers to ensure improvement in food animal health in order to increase production performance and food safety.

Contact Information

Website
www.abcelex.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3403 American Drive
  • Mississauga, Ontario L4V 1T4
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
AgTech, Supply Chain Tech, TMT, Life Sciences
Corporate Office
  • 3403 American Drive
  • Mississauga, Ontario L4V 1T4
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AbCelex Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 27-Oct-2021 Completed Out of Business
5. Accelerator/Incubator 11-Apr-2021 Completed Generating Revenue
4. Grant 29-Jul-2016 Completed Generating Revenue
3. Early Stage VC (Series A) 19-Sep-2014 Completed Startup
2. Grant 01-Apr-2014 $27K Completed Startup
1. Grant 12-Sep-2011 Completed Startup
To view AbCelex Technologies’s complete valuation and funding history, request access »

AbCelex Technologies Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

AbCelex Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020120667-A Anti salmonella antibody and use of the same Pending 04-Feb-2015
AU-2016214059-A1 Anti-salmonella antibodies and uses thereof Active 04-Feb-2015
AU-2016214059-B2 Anti-salmonella antibodies and uses thereof Inactive 04-Feb-2015
CA-2972568-A1 Anti-salmonella antibodies and uses thereof Inactive 04-Feb-2015
EP-3253789-A1 Anti-salmonella antibodies and uses thereof Inactive 04-Feb-2015 C07K16/1235
To view AbCelex Technologies’s complete patent history, request access »

AbCelex Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

AbCelex Technologies FAQs

  • When was AbCelex Technologies founded?

    AbCelex Technologies was founded in 2010.

  • Where is AbCelex Technologies headquartered?

    AbCelex Technologies is headquartered in Mississauga, Canada.

  • What is the size of AbCelex Technologies?

    AbCelex Technologies has 4 total employees.

  • What industry is AbCelex Technologies in?

    AbCelex Technologies’s primary industry is Drug Discovery.

  • Is AbCelex Technologies a private or public company?

    AbCelex Technologies is a Private company.

  • What is AbCelex Technologies’s current revenue?

    The current revenue for AbCelex Technologies is .

  • How much funding has AbCelex Technologies raised over time?

    AbCelex Technologies has raised $3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process